The effect of Glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity
Get Enough Sleep Lack of sleep disrupts hunger hormones, making cravings harder to resist
L-Carnitine in the lipid and protein protection against ethanol-induced oxidative stress
Clinically, qualifying for GLP-1 therapy typically requires meeting one of two conditions: a BMI of 30 kg/m or greater, or a BMI of 27 kg/m or greater combined with an obesity-related comorbidity such as type 2 diabetes or cardiovascular risk factors
The injection is absorbed more predictably under the skin
It helps to reduce the tremor response in Parkinson's disease patients, reduces or eliminates tissue damage in diabetic patients, improves insulin resistance, reduces respiratory problems, reduces plaque build-up, and increases blood circulation in the arteries, among other effects